Trials / Completed

CompletedNCT00348023

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

Comparison of Bimatoprost 0.03% Monotherapy vs. Dual Therapy With Travoprost 0.004% and Timolol 0.5% in Patients With Glaucoma and Ocular Hypertension

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: —

Sponsor: Innovative Medical · Industry
Sex: All
Age: 18 Years
Healthy volunteers: —

Summary

Evaluate the IOP-lowering efficacy and quality of life in patients using bimatoprost 0.03% monotherapy versus dual therapy with travoprost 0.004% and timolol 0.5% for the treatment of glaucoma or ocular hypertension.

Conditions

Glaucoma

Interventions

Type	Name	Description
DRUG	Bimatoprost 0.03%, Travoprost 0.004%, Timolol 0.5%

Timeline

First posted: 2006-07-04
Last updated: 2007-02-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00348023. Inclusion in this directory is not an endorsement.